Jerlym S Porter1, Andrew J Paladino1,2, Kathryn Russell1, Rebecca Rupff1,3, Jamilla Griffith1, Yujiao Mai4, Hui Zhang4,5, Jane S Hankins6, Winfred C Wang6. 1. Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN, USA. 2. Department of Preventive Medicine, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA. 3. Alabama College of Osteopathic Medicine, Dothan, AL, USA. 4. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA. 5. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 6. Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract
OBJECTIVE: Nocturnal enuresis is more prevalent in youth with sickle cell disease (SCD) compared to the general population. The purpose of this study is to estimate prevalence of nocturnal enuresis using diagnostic criteria and identify associated sociodemographic, medical, and health-related quality of life (HRQOL) factors. METHODS: Youth with SCD (N = 248; ages 6.00-17.99 years) and their caregivers completed semi-structured interviews and questionnaires. HRQOL was measured using the Pediatric Quality of Life (PedsQL) Inventory. Medical information was abstracted from medical record. We generated multivariable logistic regression models to examine associations between factors and current nocturnal enuresis and nocturnal enuresis occurring any time in the past (lifetime). RESULTS: Among participants (mean age, 11.3 ± 3.6 years; 50.8% male), 21.4% reported current nocturnal enuresis and 46% reported lifetime nocturnal enuresis. Male sex [odds ratio (OR), 2.57; p = .001], difficulty arousing from sleep (OR, 3.57; p < .001), higher school functioning HRQOL (OR, 1.02; p = .014), and higher fetal hemoglobin levels (OR, 1.03; p = .048) were associated with lifetime nocturnal enuresis. Younger age (OR, 1.16; p = .005), higher youth-reported fatigue (OR, 1.01; p = .045), difficulty arousing from sleep (OR, 4.92; p < .001), and higher lactate dehydrogenase levels (OR, 1.00; p = .042) were associated with current nocturnal enuresis. CONCLUSIONS: Nocturnal enuresis is prevalent in youth with SCD and is associated with HRQOL, diminished sleep, greater fatigue, and disease severity markers. Routine assessment of sleep behaviors and fatigue are necessary when treating patients with SCD to understand the impact of nocturnal enuresis on HRQOL.
OBJECTIVE: Nocturnal enuresis is more prevalent in youth with sickle cell disease (SCD) compared to the general population. The purpose of this study is to estimate prevalence of nocturnal enuresis using diagnostic criteria and identify associated sociodemographic, medical, and health-related quality of life (HRQOL) factors. METHODS: Youth with SCD (N = 248; ages 6.00-17.99 years) and their caregivers completed semi-structured interviews and questionnaires. HRQOL was measured using the Pediatric Quality of Life (PedsQL) Inventory. Medical information was abstracted from medical record. We generated multivariable logistic regression models to examine associations between factors and current nocturnal enuresis and nocturnal enuresis occurring any time in the past (lifetime). RESULTS: Among participants (mean age, 11.3 ± 3.6 years; 50.8% male), 21.4% reported current nocturnal enuresis and 46% reported lifetime nocturnal enuresis. Male sex [odds ratio (OR), 2.57; p = .001], difficulty arousing from sleep (OR, 3.57; p < .001), higher school functioning HRQOL (OR, 1.02; p = .014), and higher fetal hemoglobin levels (OR, 1.03; p = .048) were associated with lifetime nocturnal enuresis. Younger age (OR, 1.16; p = .005), higher youth-reported fatigue (OR, 1.01; p = .045), difficulty arousing from sleep (OR, 4.92; p < .001), and higher lactate dehydrogenase levels (OR, 1.00; p = .042) were associated with current nocturnal enuresis. CONCLUSIONS: Nocturnal enuresis is prevalent in youth with SCD and is associated with HRQOL, diminished sleep, greater fatigue, and disease severity markers. Routine assessment of sleep behaviors and fatigue are necessary when treating patients with SCD to understand the impact of nocturnal enuresis on HRQOL.
Authors: Carol L Rosen; Michael R Debaun; Robert C Strunk; Susan Redline; Sinziana Seicean; Daniel I Craven; Johanna C D Gavlak; Olu Wilkey; Baba Inusa; Irene Roberts; R Lucas Goodpaster; Beth Malow; Mark Rodeghier; Fenella J Kirkham Journal: Pediatrics Date: 2014-07-14 Impact factor: 7.124
Authors: Gloria C Lehmann; Teal R Bell; Fenella J Kirkham; Johanna C Gavlak; Tekeda F Ferguson; Robert C Strunk; Paul Austin; Carol L Rosen; Melanie J Marshall; Olu Wilkey; Mark J Rodeghier; John O Warner; Michael R DeBaun Journal: J Urol Date: 2012-08-19 Impact factor: 7.450
Authors: P L Whitesell; O Owoyemi; P Oneal; M Nouraie; E S Klings; A Rock; T A Mellman; T Berihun; J Lavella; R E Taylor; S P Perrine Journal: Sleep Med Date: 2016-06-23 Impact factor: 3.492
Authors: Robert I Liem; Sophie Lanzkron; Thomas D Coates; Laura DeCastro; Ankit A Desai; Kenneth I Ataga; Robyn T Cohen; Johnson Haynes; Ifeyinwa Osunkwo; Jeffrey D Lebensburger; James P Lash; Theodore Wun; Madeleine Verhovsek; Elodie Ontala; Rae Blaylark; Fares Alahdab; Abdulrahman Katabi; Reem A Mustafa Journal: Blood Adv Date: 2019-12-10
Authors: Julie A Panepinto; Nicholas M Pajewski; Lisa M Foerster; Raymond G Hoffmann Journal: J Pediatr Hematol Oncol Date: 2008-09 Impact factor: 1.289
Authors: Alana de Medeiros Nelli; Flavia Cristina de Carvalho Mrad; Mateus de Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; Cristiano Mendes Gomes; José Murillo Bastos; Jose de Bessa Journal: Int Braz J Urol Date: 2019 Sep-Oct Impact factor: 3.050
Authors: Rima S Zahr; Juan Ding; Guolian Kang; Winfred C Wang; Jane S Hankins; Kenneth I Ataga; Jeffrey D Lebensburger; Jerlym S Porter Journal: J Pediatr Hematol Oncol Date: 2022-02-18 Impact factor: 1.170